missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Phafin 1 (aa 1-128) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (98%), Rat (98%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55268 (PA5-55268. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
APPD (Apoptosis-inducing protein D; phafin 1) is predicted through gene annotation and contains pleckstrin homology domain. It may binds to two Zn++ ions through its FYVE zinc finger domain. Biological function of this protein has not been clearly mapped yet.
Specifications
Specifications
| Accession Number | Q96S99 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 79156 |
| Name | Human Phafin 1 (aa 1-128) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1810013P09Rik; AI037048; Apoptosis-inducing protein; apoptosis-inducing protein D; APPD; Lapf; lysosome-associated apoptosis-inducing protein containing PH and FYVE domains; PH and FYVE domain-containing protein 1; PH domain-containing family F member 1; phafin 1; PHAFIN1; phafin-1; pleckstrin homology and FYVE domain containing 1; pleckstrin homology domain containing, family F (with FYVE domain) member 1; pleckstrin homology domain-containing family F member 1; Plekhf1; SGP-1; ZFYVE15; Zinc finger FYVE domain-containing protein 15 |
| Common Name | Phafin 1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction